Raymond James analyst Jayson Bedford maintained a Hold rating on Senseonics Holdings (SENS – Research Report) yesterday. The company’s shares closed last Tuesday at $0.41, close to its 52-week low of $0.36.
According to TipRanks.com, Bedford is a 5-star analyst with an average return of 16.0% and a 70.7% success rate. Bedford covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, Edwards Lifesciences, and Tandem Diabetes Care.
Senseonics Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $0.80.
The company has a one-year high of $1.78 and a one-year low of $0.36. Currently, Senseonics Holdings has an average volume of 2.52M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.